Bliss GVS Pharma Limited has informed the Exchange about Rumour Verification - Regulation 30(11)
BLISSGVS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
A news item on CNBC आवाज़ on February 13, 2026 reported that Bliss GVS Pharma may acquire Anupam Rasayan. The company has formally clarified that this news item is purely speculative and did not originate from any official communication from the company. As of date, the promoters have not made, finalised, or approved any decision or arrangement regarding this matter. The company stated that no information currently warrants disclosure under SEBI's Listing Regulations. Investors have been advised to rely only on official disclosures made by the company to the stock exchanges.
This is a denial of an acquisition rumor, which may help calm any speculative trading in the stock triggered by the CNBC report. Shareholders should treat the rumored acquisition as unconfirmed and not act on it until an official announcement is made by the company.